|Activity Title||Adult Pneumococcal Disease Education: Integrated Regional Learning Series|
|Topic||Adult Pneumococcal Disease|
|Target Audience||Adult primary care physicians including family physicians, internists, and generalists|
|Release Date||June 2010|
|Expiration Date||June 30, 2011|
|Estimated Time to Complete Activity||60 minutes|
Upon completion of the activity, participants should be able to:
- Indicate the current burden of pneumococcal disease among adults and identify profiles of specific patients at greatest risk for these preventable diseases
- Identify challenges facing adequate treatment of pneumococcal disease in adults, such as the emergence of non-vaccine serotype disease and trends in antibiotic-resistance, and define how these elements impact clinical decision making
- Describe specific barriers that prevent the proper immunization of adults against pneumococcal disease, and define future strategies for overcoming these barriers
FACULTY– CONTENT CREATORS
Alison G. Freifeld, MD, FIDSA (Chairperson)
Professor of Internal Medicine
Infectious Disease Section
Immunocompromised Host Infectious Diseases Program
University of Nebraska Medical Center
Keith P. Klugman, MB BCh, PhD, FAAM, FIDSA
William H. Foege Chair of Global Health
Hubert Department of Global Health
Rollins School of Public Health
Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine
University of Minnesota Medical School
Associate Chief of Staff for Research
Minneapolis VA Medical Center
Jorge P. Parada, MD, MPH, FACP, FIDSA
Associate Professor of Medicine
Department of Medicine
Stritch School of Medicine
Infection Control Program
Loyola University Medical Center and Health System
This activity is sponsored by the University of Nebraska Medical Center, Office of Continuing Education and The France Foundation.
Adult primary care physicians including family physicians, internists, and generalists.
STATEMENT OF NEED
This activity has been planned in accordance with the need to provide education surrounding the burden of pneumococcal disease, its treatment, prevention, and improved management specifically among adults in Puerto Rico.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
It is the policy of The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation have identified and resolved any and all conflicts of interest prior to the release of this activity.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The University of Nebraska Medical Center, Center for Continuing Education who control content have no relevant financial relationships to disclose.
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty Disclosures – Content Creators
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:
- Alison G. Freifeld, MD, FIDSA, has received grant/research support from Enzon, National Institutes of Health, and Vical.
- Keith P. Klugman, MB BCh, PhD, FAAM, FIDSA, has received grant/research support from Johnson and Johnson and Wyeth and has served as a consultant for GlaxoSmithKline, Merck, Novartis, sanofi-aventis, and Wyeth.
- Kristin L. Nichol, MD, MPH, MBA, has received grant/research support from GlaxoSmithKline, MedImmune, and Sanofi-Pasteur. Dr. Nichol has served as a consultant for CSL, GlaxoSmithKline, MedImmune, Merck, Novartis, Sanofi-Pasteur, and Wyeth.
Faculty Disclosure – Activity Presenter
The following faculty have reviewed the content and indicated they have relationships with industry to disclose relative to the content of this CME activity:
- Jorge P. Parada, MD, MPH, FACP, FIDSA, has received grants/research support from Pfizer and Hoffmann-La Roche Inc., and has served as a consultant for Clarity, Merck, and Pfizer. He has received honoraria from Cepheid, Pfizer, and ViroPharma.
UNAPPROVED USE DISCLOSURE
The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation require CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Wyeth Pharmaceuticals.
The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, The France Foundation, and Wyeth Pharmaceuticals assume no liability for the information herein.
Copyright © 2010 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or firstname.lastname@example.org.